Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM

Diabetes Care

Volumn 19, Issue 11, 1996, Pages 1243-1248

  Savage, Susan ^a   Estacio, Raymond O ^b   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; EXERCISE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 0029855129     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.11.1243     Document Type: Article

References (45)

1. Rubin RJ, Altman WM, Mendelson DN: Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinlo Metab 78:809A-809F, 1994
2. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
3. Mogensen C: Microalbuminuria as a predictor of clinical diabetic nephropathy in insulin-dependent diabetics. Kidney Int 31:673-689,1989
4. Tuttle KR, Stein JH, DeFronzo RA: The natural history of diabetic nephropathy. Semin Nephml 10:184-193,1990
5. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319-323,1992
6. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G: Prospective study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes 41:736-741,1992
7. Klein R, Klein BE, Moss SE: Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 16:1325-1330,1993
8. Gall MA, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P: Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulindependent) diabetic patients. Diabetologia 34:655-661,1991
9. Falkenberg M, Finnstrom K: Associations with retinopathy in type 2 diabetes: a population-based study in a Swedish rural area. Diabetic Med 11:843-849,1994
10. Erasmus RT, Oyeyinka G, Arije A: Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy. Postgrad Med J 68:638-642, 1992
11. Niskanen L, Voutilainen R, Terasvirta M, Lehtinen J, Teppo AM, Groop L, Uusitupa M: A prospective study of clinical and metabolic associates of proteinuria in patients with type 2 diabetes mellitus. Diabetic Med 10:543-549,1993
12. Savage S, Johnson Nagel N, Estacio RO, Feig PU, MacCarthy EP, Lukken NJ, Ziegler R, Schrier RW: The ABCD (Appropriate Blood Pressure Control in Diabetes) Trial: rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes. Online J Curr Gin Trials 2:1993
13. Schrier R\Y Savage S: Appropriate Blood Pressure Control in Diabetes (ABCD) Trial: implications for complications. Am J Kid-. ney Dis 6:653-657,1992
14. World Health Organization: Diabetes Mellitiis: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Sen, No. 727)
15. National Diabetes Data Group: Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance. Diabetes 28:1039-1057,1979
16. Klenk DC: Determination of glycosylated hemoglobin by affinity chromatography: comparison with calorimetric and ion exchange methods and effects of common interferences. Clin Chem 28:2088-2094, 1982
17. Fossati P, Drencipe L: Serum triglycérides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080,1982
18. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. C!in Chem 20:470-474, 1973
19. Assman G, Schriewer H, Schmilz G: Quantification of high-density lipoprotein cholesterol by precipitation with phosphotungstic acid/MgC12. Clin Chem 29:20262030,1983
20. Mogensen CE: Microalbuminuria in diabetic renal disease. In Prevention and Treatment of Diabetic Late Complications. Mogensen CE, Standl E., Eds. New York, Walter de Gruyter, 1989, p. 41-73
21. Hilbome LH, Lin PC, Higgins SA, Rodgerson DO: Evaluation of the Behring neph-elometer for detection of low level urinary albumin. Am J Clin Pathol 93:405-410, 1990
22. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the Modified Airlie House Classification: ETDRS repon number 10. Ophthalmology 98:786-806, 1991
23. Consensus Panel: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Ann Neural 24:99-106, 1988
24. Rose GA: Cardiovascular Survey Methods. World Health Org., Geneva, 1982 (monogr. no. 56)
25. Hiatt WR, Marshall JA, Baxter], Sandoval R, Hildebrandt W, Kahn LR, Hamman RF: Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemic! 43:597-606, 1990
26. Bruce RA: Exercise testing of patients with coronary artery disease. Ann C!in Res 3:323-332,1971
27. Romolt D\Y Bove KE, Morris RJ: A critical appraisal of the electrocardiographic criteria for the diagnosis of left ventricular hypertrophy. Circulation 20:185-189, 1969
28. Sokolow M, Lyon TP: The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 37:161,1949
29. Casale PN, Devereux RB, Alonso DR, Campo E, Klingfild P: Improved sex-specific criteria of left ventricular hypertrophy for clinical computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 75:565-572, 1987
30. Savage S, Johnson Nagel N, Estacio RO, Lukken N, Schlier RW: Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 25:836-844,1995
31. Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR: Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-year follow-up study. Diabetes Care 9:443-452, 1986
32. Pirart J: Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1:168-188, 252-261,1978
33. The Diabetes Control and Complications Trial Study Group: The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes melli-tus. N Eng! JMed 329:304-307, 1993
34. Parving HH, Hommel E, Malhiesen E, Skott P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E: Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br MedJ 296:156-160,1988
35. Decken T, Feldt-Rasmussen B, BorchJohnson K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno Hypothesis. Diabetologia 32:219-226,1989
36. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M: Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Eng! ] Med 333:89-94, 1995
37. The DCCT Research Group: Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase Diabetes Control and Complications Trial (DCCT). Diabetes 37:476-481,1988
38. Masser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA, Orchard Tj: Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38:1456-1461,1989
39. Bell DS, Ketchum CH, Robinson CA, Wagenknecht LE, Williams BT: Microalbuminuria associated with diabetic neuropathy. Diabetes Care 15:528, 1992
40. L Dyck P, Karnes J, O'Brien P: The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neural 19:440-449,1986
41. Sträub RH, Thum M, Hollerbach C, Palitzsch KD, Scholmerich J: Impact of obesity on neuropathic late complications in NIDDM. Diabetes Care 17:1290-1294, 1994
42. Kannel WB, Stampfer JM, Castelli WP: The prognostic significance of proteinuria: the Framingham Study. Am Heart J 108:1347-1352,1984
43. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC: The effect of proteinuria on mortality in non-insulin-dependent diabetes mellitus. Diabetes 37:1499-1504,1988
44. Schmilz A, Vaeth M: Microalbuminuria: a major risk factor in non-insulin-dependent diabetes: a 10-year follow-up study of 503 patients. Diabetic Med 5:126-134, 1988
45. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360,1984